3rd SCI-RSC symposium on antimicrobial drug discovery

Synopsis

At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.

Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.

---

Attendees

Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery.  And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.

---

Venue and Contact

---

Booking Process/Deadlines

Booking terms and conditions

---

CPD Info

SCI Members attending this meeting are able to claim CPD points.

---

---

---

Organising Committee

• Dr Liam Cox, SCI / University of Birmingham
• Dr Caroline Low, SCI / Computational Medicinal Chemistry Consultant
• Dr Pascal Savy, SCI / Charles River Laboratories
• Dr Francis Wilson, RSC / Summit Therapeutics

---